The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients (Pts) with advanced hepatocellular carcinoma (aHCC): Long-term results from CheckMate 040.
 
Anthony B. El-Khoueiry
Honoraria - Agenus; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Eisai; EMD Serono; Exelixis; Gilead Sciences; Merck; Pieris Pharmaceuticals; Roche/Genentech
Consulting or Advisory Role - Agenus; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Eisai; EMD Serono; Exelixis; Gilead Sciences; Merck; Pieris Pharmaceuticals; Roche
Research Funding - Astex Pharmaceuticals; AstraZeneca; Merck
 
Thomas Yau
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology
Consulting or Advisory Role - Bristol-Myers Squibb
 
Yoon-Koo Kang
Consulting or Advisory Role - ALX Oncology; Amgen; Bristol-Myers Squibb; DAEHWA Pharmaceutical; Macrogenics; Novartis; Surface Oncology; Zymeworks
 
Tae-You Kim
No Relationships to Disclose
 
Armando Santoro
Consulting or Advisory Role - ARQULE; Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; MSD; Pfizer; Sanofi; SERVIER
Speakers' Bureau - Abbvie; Amgen; ArQule; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Eisai; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Sandoz; Servier; Takeda
 
Bruno Sangro
Consulting or Advisory Role - Adaptimmune; AstraZeneca; Bayer; Bristol-Myers Squibb; BTG; H3 Biomedicine; Ipsen; Lilly; Merck; Roche/Genentech; Sirtex Medical
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Ipsen; Lilly; Sirtex Medical
Research Funding - Bristol-Myers Squibb (Inst); Sirtex Medical (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; Sirtex Medical
Other Relationship - Medscape; Target Pharmasolutions
 
Ignacio Melero
Honoraria - Bioncotech; PharmaMar
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; Bayer; Boston Pharmaceuticals; Bristol-Myers Squibb; crispr therapeutics; EMD Serono; F-star; Genmab; Lilly; MSD; Noxxon Pharma; Numab; Pieris Pharmaceuticals; Roche/Genentech; SERVIER; Tusk Therapeutics; Tusk Therapeutics
Research Funding - Alligator Bioscience; AstraZeneca; Bioncotech; Bristol-Myers Squibb; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Incyte; MSD; Roche/Genentech
 
Masatoshi Kudo
Honoraria - Bayer; Bristol-Myers Squibb Japan; EA Pharma; Eisai; Lilly Japan; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; MSD; Ono Pharmaceutical; Roche
Research Funding - Abbvie (Inst); EA Pharma (Inst); Eisai (Inst); Gilead Sciences (Inst); Otsuka (Inst); Sumitomo Dainippon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Ming-Mo Hou
No Relationships to Disclose
 
Ana Matilla
Consulting or Advisory Role - Bayer; Eisai
Speakers' Bureau - Bayer; Boston Scientific; Eisai
Travel, Accommodations, Expenses - Bayer
 
Francesco Tovoli
Consulting or Advisory Role - Bayer; Guerbet
 
Jennifer J. Knox
Honoraria - Novartis; Roche Canada
Consulting or Advisory Role - AstraZeneca/MedImmune; Lilly; Merck
Research Funding - AstraZeneca; Ipsen; Merck
Expert Testimony - AstraZeneca
 
Aiwu Ruth He
Consulting or Advisory Role - Eisai; Genentech/Roche; Merck
Speakers' Bureau - Bristol-Myers Squibb; Eisai; Exelixis
Research Funding - Genentech; Merck
 
Bassel F. El-Rayes
Honoraria - Bayer; Lexicon; RTI Health Solutions
Consulting or Advisory Role - Bayer; BTG; Loxo; Merck; Merrimack; RTI Health Solutions
Speakers' Bureau - Bristol-Myers Squibb; Lexicon
Research Funding - AstraZeneca/MedImmune (Inst); AVEO (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Cleave Biosciences (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Hoosier Cancer Research Network (Inst); ICON Clinical Research (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); PPD (Inst); Taiho Pharmaceutical (Inst); Xencor (Inst)
Other Relationship - ERYTECH Pharma; Exelixis
 
Mirelis Acosta-Rivera
Consulting or Advisory Role - Eisai; Merck
Speakers' Bureau - Bristol-Myers Squibb; Eisai; Merck
 
Ho Yeong Lim
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb/Medarex; Eisai; MSD Oncology
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai
Speakers' Bureau - Bayer
 
Arteid Memaj
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Ashwin Reddy Sama
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Chiun Hsu
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb-Ono Pharmaceutical; Eisai; Ipsen; Lilly; Merck Serono; MSD; Novartis; PharmaEngine; Roche; TTY Biopharm
Research Funding - Bristol-Myers Squibb-Ono Pharmaceutical; Ipsen; Roche
Travel, Accommodations, Expenses - Ipsen; PharmaEngine; Roche; TTY Biopharm